ProPhase Labs, Inc. Debt Instrument, Face Amount
ProPhase Labs, Inc. (PRPH) had Debt Instrument, Face Amount of $300.00 thousand as of 2020-10-22, per its 10-K filed 2022-03-31.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2022-03-31
- 2020-10-22: Debt Instrument, Face Amount $300.00K.
- 2016-12-31: Debt Instrument, Face Amount $1.50M.
- 2015-12-31: Debt Instrument, Face Amount $1.47M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2020-10-22 | $300.00K 10-K · filed 2022-03-31 |
| 2016-12-31 | $1.50M 10-K/A · filed 2018-08-20 |
| 2015-12-31 | $1.47M 10-K · filed 2017-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |